Pfizer is also demonstrating that its commercial portfolio can flourish beyond the historically mammoth sales of its COVID-19 ...

Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, ...

Pfizer posted better-than-expected quarterly earnings on Tuesday and said a recent favorable European court ruling on its ...

Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...

The suspicion bubbling up around the unreleased vaccine, Offit says, precisely calls to mind what has happened to vaccines ...